Harnessing real-world data to inform treatment decisions in multiple sclerosis

机译：Correction: Real-world use of natalizumab in Austria: data from the Austrian Multiple Sclerosis Treatment Registry (AMSTR)

机译：Real-world use of natalizumab in Austria: data from the Austrian Multiple Sclerosis Treatment Registry (AMSTR)

机译：“If they’re highly symptomatic and they need an immediate response, I think there’s still room to make a case for much more aggressive triplet therapy....Most likely, what we’ll have to do is come together as a medical community to understand what the real-world data tell us, to help inform some of these decision-making processes. For patients with low-volume disease, I’m still mostly thinking about doublet therapies.”

机译：EQ-5D-5L未捕获的与健康相关的生活质量方面：IMPrESS（International MultiPlE SclerosiS）研究的结果

机译：Rocky mountain arsenal North Boundary Treatment Facility：Chemical Data，1985。